Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0006826
Disease: Malignant Neoplasms
Malignant Neoplasms
0.020 AlteredExpression group BEFREE Among many differentially expressed genes, eIF2alpha kinase, a heme regulated inhibitor was down-regulated in ovarian epithelium cancer. 11101152 2000
CUI: C0006826
Disease: Malignant Neoplasms
Malignant Neoplasms
0.020 Biomarker group BEFREE We review aspects of targeting eIF2 signaling in cancer and highlight promising data using HRI activators against tumor cells. 29063813 2017
CUI: C0019045
Disease: Hemoglobinopathies
Hemoglobinopathies
0.020 Biomarker group BEFREE Taken together, these results suggest HRI as a potential therapeutic target for hemoglobinopathies. 30026227 2018
CUI: C0019045
Disease: Hemoglobinopathies
Hemoglobinopathies
0.020 Biomarker group BEFREE Heme-regulated inhibitor (HRI), an eukaryotic translation initiation factor 2 alpha (eIF2α) kinase, plays critical roles in cell proliferation, differentiation, adaptation to stress, and hemoglobin disorders. 28590739 2017
CUI: C1306459
Disease: Primary malignant neoplasm
Primary malignant neoplasm
0.020 AlteredExpression group BEFREE Among many differentially expressed genes, eIF2alpha kinase, a heme regulated inhibitor was down-regulated in ovarian epithelium cancer. 11101152 2000
CUI: C1306459
Disease: Primary malignant neoplasm
Primary malignant neoplasm
0.020 Biomarker group BEFREE We review aspects of targeting eIF2 signaling in cancer and highlight promising data using HRI activators against tumor cells. 29063813 2017
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.010 AlteredExpression group BEFREE Expert opinion: Pharmacologic activation of HRI inhibits tumor growth as a single agent without appreciable toxicity in vivo. 29063813 2017
CUI: C0033975
Disease: Psychotic Disorders
Psychotic Disorders
0.010 GeneticVariation group BEFREE This study examined the predictive validity of the Spanish version of the Suicide Risk Assessment Manual (S-RAMM) and the <i>Historical-Clinical-Risk Management-20</i> (HCR-20) in a sample of violent offenders with schizophrenia and other psychosis, who had committed violent crimes and had been sentenced to compulsory psychiatric treatment by the criminal justice system. 30131743 2018
CUI: C0037274
Disease: Dermatologic disorders
Dermatologic disorders
0.010 AlteredExpression group BEFREE To understand better the function of HCR, we studied how HCR expression is altered in hyperproliferative skin diseases other than psoriasis and in cancers. 14675183 2003
CUI: C0038002
Disease: Splenomegaly
Splenomegaly
0.300 Biomarker phenotype CTD_human Heme-regulated eIF2α kinase plays a crucial role in protecting erythroid cells against Pb-induced hemolytic stress. 25411909 2015
CUI: C0860207
Disease: Drug-Induced Liver Disease
Drug-Induced Liver Disease
0.300 Biomarker phenotype CTD_human Heme-regulated eIF2α kinase plays a crucial role in protecting erythroid cells against Pb-induced hemolytic stress. 25411909 2015
CUI: C0200635
Disease: Lymphocyte Count measurement
Lymphocyte Count measurement
0.100 GeneticVariation phenotype GWASDB The combination of a genome-wide association study of lymphocyte count and analysis of gene expression data reveals novel asthma candidate genes. 22286170 2012
Red cell distribution width determination
0.100 GeneticVariation phenotype GWASCAT Leveraging Polygenic Functional Enrichment to Improve GWAS Power. 30595370 2019
RDW - Red blood cell distribution width result
0.100 GeneticVariation phenotype GWASCAT Leveraging Polygenic Functional Enrichment to Improve GWAS Power. 30595370 2019
CUI: C0042693
Disease: Violence
Violence
0.080 GeneticVariation phenotype BEFREE This study investigated the differential predictive validity and potential for disparate impact of both juvenile (the Structured Assessment of Violence Risk for Youth and Youth Level of Service/Case Management Inventory) and adult risk assessment instruments (the Historical-Clinical-Risk Management-20 [HCR-20] and the Violence Risk Appraisal Guide [VRAG]) with this age group (ages 16-24), relative to adolescents (ages 12-15) or older adults (ages 25-40). 30570311 2019
CUI: C0042693
Disease: Violence
Violence
0.080 Biomarker phenotype BEFREE Patient progress was evaluated using the DUNDRUM-3, a measure of patient ability to participate and benefit from multi-modal psychosocial programs and the HCR-20 dynamic items, a measure of violence proneness. 30195335 2018
CUI: C0042693
Disease: Violence
Violence
0.080 GeneticVariation phenotype BEFREE Violence risk ratings (measured by the Historical Clinical Risk Management-20 [HCR-20]) and psychopathy ratings (measured by the Psychopathy Checklist-Revised [PCL-R]) depended on the presence of a prior criminal record, such that those with a prior criminal record were perceived as a greater violence risk and as exhibiting more psychopathic traits than their clean-record counterparts. 31096835 2019
CUI: C0042693
Disease: Violence
Violence
0.080 GeneticVariation phenotype BEFREE The domain of inattention and omission errors was related to occupational/vocational therapy engagement as well as a higher risk of present and future violence as measured by the HCR-20. 31133891 2019
CUI: C0042693
Disease: Violence
Violence
0.080 GeneticVariation phenotype BEFREE Patients scoring above the mean on the S-RAMM (>20-point cut-off) had a five times increased risk of suicide related events (OR = 5.05, 95% CI = 2.6-9.7) and sevenfold risk of violence in the HCR-20 (>21-point cut-off) (OR = 7.13, 95% CI = 2.0-21.2) than those scoring below the mean. 30131743 2018
CUI: C0042693
Disease: Violence
Violence
0.080 Biomarker phenotype BEFREE <b>Purpose and aim:</b> Out from the sparse literature on risk assessment for violence committed by women the Female Additional Manual (FAM) was developed to be a complement to the HCR-20v2. 31081436 2019
CUI: C0042693
Disease: Violence
Violence
0.080 GeneticVariation phenotype BEFREE Among the assessment tools forensic evaluators use to assess violence risk are the Violence Risk Appraisal Guide (VRAG; Quinsey, Harris, Rice, & Cormier, ) and the Historical Clinical Risk Managment-20 (HCR-20)/Historical Clinical Risk Management-20, Version 3 (HCR-20<sup>V3</sup> ) (Webster, Douglas, Eaves, & Hart, and Douglas, Hart, Webster, & Belfrage, , respectively). 30277618 2018
CUI: C0042693
Disease: Violence
Violence
0.080 Biomarker phenotype BEFREE Area under the curve analyses suggested that the HCR-20 total score is a good predictor of violence in this cohort, with the clinical and risk sub-scales showing good predictive accuracy, but the historical sub-scale not doing so. 27296667 2017
CUI: C0015967
Disease: Fever
Fever
0.020 Biomarker phenotype BEFREE To clarify the role of the p53 gene and apoptosis in combined hyperthermia, chemotherapy and radiation (hyperthermochemoradiotherapy, HCR therapy) for rectal cancer, we examined the histological response, rate of apoptosis, DNA fragmentation and p53 status in tumours from 28 patients undergoing HCR therapy before surgery and from 22 patients who did not have preoperative treatment. 9459162 1998
CUI: C0015967
Disease: Fever
Fever
0.020 Biomarker phenotype BEFREE When the catalytic kinase domain of the HRI (HRI.CKD) protein was subjected to high temperature, 45°C (above mammalian heat shock temperature), it could still phosphorylate the substrate, indicating its potential as a stress response kinase. 27888007 2017
CUI: C0030193
Disease: Pain
Pain
0.010 Biomarker phenotype BEFREE The LCR and HCR rats should prove useful as models to assess how the metabolic status impacts pain. 29075557 2017